Similarly, PC3M, the highly metastatic derivative expressed 18 times higher levels of osteonectin compared with their parental PC3 cells that was originally derived from bone metastases of prostate cancer (Fig 1A). This evidence concerns the gene SPARC and prostate carcinoma.